PreEvnt’s isaac system enters human clinical trials, bringing non-invasive, breath-based glucose monitoring closer to a late ...
Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback